Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The more you exercise, the less likely you are to die after a lung or colorectal cancer diagnosis.
As smoking rates decline, the proportion of lung cancer cases that are among never smokers is increasing.
Nancy Davidson, MD, on improving outcomes for women with breast, lung and colorectal cancer
Researchers continue to develop new drugs that target cancer with specific genetic mutations anywhere in the body.
A closer look at how generating electricity affects health
Christine M. Lovly, MD, PhD, is targeting lung cancer.
Progression-free and overall survival improved in patients treated with Tecentriq plus chemotherapy.
A new breed of patient advocate is reshaping the future of cancer research.
Study suggests current lung cancer screening guidelines may be inadequate for HIV-positive people.
Multipronged approach eliminated treatment gaps between black and white patients and improved overall treatment rates.
The cost of treating complications of invasive diagnostic procedures can be substantial.
Lung cancer advocate Don Stranathan takes on the No. 1 cancer killer.
David MacPherson, PhD, discusses the state of SCLC research, how his lab is tackling the disease and what makes him excited for the future.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.